Skip to main content

Day: October 23, 2019

PyroGenesis Announces Closing of Small Non-Brokered Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESMONTREAL, Oct. 23, 2019 (GLOBE NEWSWIRE) — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V: PYR) (OTCQB: PYRNF) (FRA: 8PY), a high-tech company, (the “Company”, the “Corporation” or “PyroGenesis”) a Company that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch products, is pleased to announce today that it has closed a non-brokered private placement financing (the “Offering”) for gross proceeds of approx. $168,000, by issuing 300,000 Units at a price of $0.56 per Unit.Each Unit will consist of one (1) common share in the capital of the Company (“Common Share”) and three-quarters (0.75) of a Common Share purchase...

Continue reading

Surrey Bancorp Reports Third Quarter Net Income of $1,676,806

MOUNT AIRY, N.C., Oct. 23, 2019 (GLOBE NEWSWIRE) — Surrey Bancorp (the “Company”), (Pink Sheets: SRYB), the holding company for Surrey Bank & Trust, today reported earnings for the third quarter of 2019.For the quarter ended September 30, 2019, net income totaled $1,676,806 or $0.40 per fully diluted share, compared to $1,276,940 or $0.31 per fully diluted common share earned during the third quarter of 2018. The increase in net interest income is due to loan growth and an improved net interest margin. Average loans outstanding in the third quarter of 2019 amounted to $243,071,559 compared to $235,525,596 in the third quarter of 2018. Loan yields increased from 5.53 percent in the third quarter of 2018 to 6.10 percent in the same quarter of 2019 due to the recapture of interest income and late fees on a government guaranteed...

Continue reading

AB Klaipėdos nafta (KN) will hold an Investor Conference Webinar to introduce unaudited financial results for the nine months of 2019

KN invites shareholders, investors, analysts and other stakeholders to join its investor conference webinar scheduled on the October 30th of 2019 at 8.30 am (EET). The presentation will be held in English.The webinar will be hosted by Company’s management who will introduce the performance and unaudited financial results of KN for the nine months of 2019.After the presentation investors are welcome to ask questions. Due to limited webinar time, we encourage participants to send their questions before the webinar until October 28th to Justinas.Juknys@nasdaq.comHow to join the webinar?To join the webinar, please register via following link: https://attendee.gotowebinar.com/register/2162981666275406850 You will be provided with the webinar link and instructions how to join successfully. When joining the webinar for the first time, you will...

Continue reading

Kvietimas į AB „Klaipėdos nafta“ (KN) 2019 metų devynių mėnesių neaudituotų finansinių rezultatų pristatymą internetiniame seminare

Š.m. spalio 30 d. 8.30 val. KN kviečia akcininkus, investuotojus, analitikus ir visus besidominčius į 2019 metų devynių mėnesių neaudituotų finansinių rezultatų pristatymą internetiniame seminare (angl. „webinar“), kuris vyks anglų kalba.Bendrovės 2019 metų devynių mėnesių neaudituotus finansinius rezultatus komentuos ir po prezentacijos į dalyvių klausimus atsakys Bedrovės vadovai.Dėl riboto seminarui skirto laiko maloniai prašome atsiųsti klausimus iš anksto iki 2019 m. spalio 28 dienos el. paštu: Justinas.Juknys@nasdaq.comKaip prisijungti prie internetinio seminaro?Visus norinčius dalyvauti internetiniame seminare, prašome registruotis aktyvuojant šią nuorodą: https://attendee.gotowebinar.com/register/2162981666275406850 Jums bus išsiųsta nuoroda prisijungti į internetinį seminarą ir instrukcija, kaip sėkmingai tai padaryti. Jungiantis...

Continue reading

Logansport Financial Corp. Reports Net Earnings for the Quarter Ended September 30, 2019

LOGANSPORT, Ind., Oct. 23, 2019 (GLOBE NEWSWIRE) — Logansport Financial Corp., (OTCBB, LOGN), parent company of Logansport Savings Bank, reported net earnings for the quarter ended September 30, 2019 of $602,000 or $.98 per diluted share, compared to earnings in 2018 of $556,000 or $.90 per diluted share. Year to date the company reported net earnings of $1,662,000 for 2019 compared to $1,671,000 for 2018. Diluted earnings per share for the nine months ended September 30, 2019 were $2.71 compared to $2.69 for the nine months ended September 30, 2018. Total assets at September 30, 2019 were $186.1 million compared to total assets at September 30, 2018 of $173.9 million. Cash dividends to shareholders Year to Date in 2019 total $3.80 compared to $1.00 in 2018, due in large part to the special dividend of $2.75 paid to shareholders in...

Continue reading

Minerals Technologies Declares Quarterly Dividend

NEW YORK, Oct. 23, 2019 (GLOBE NEWSWIRE) — Minerals Technologies Inc. (NYSE: MTX) today declared a regular quarterly dividend of $0.05 per share on the Company’s common stock. The dividend is payable on December 12, 2019 to stockholders of record on November 4, 2019.About Minerals Technologies Inc.New York-based Minerals Technologies Inc. (MTI) is a resource- and technology-based growth company that develops, produces and markets worldwide a broad range of specialty mineral, mineral-based and synthetic mineral products and related systems and services. MTI serves the paper, foundry, steel, construction, environmental, energy, polymer and consumer products industries. The company reported sales of $1.808 billion in 2018. For further information, please visit our website at www.mineralstech.com. (MTI-D)

Continue reading

Daseke, Inc. to Release Third Quarter 2019 Results on November 12, 2019

ADDISON, Texas, Oct. 23, 2019 (GLOBE NEWSWIRE) — Daseke, Inc. (NASDAQ: DSKE) (or the “Company”), the largest flatbed, specialized transportation and logistics solutions company in North America, today announced that it plans to report results for its fiscal third quarter ended September 30, 2019 on November 12, 2019. A conference call to discuss the financial and operational results is scheduled for November 12, 2019 at 11:00 AM ET.Investors, analysts, and members of the media interested in listening to the live presentation are encouraged to join a webcast of the call with accompanying presentation slides, available on the Company’s website at https://www.daseke.com. Interested parties may also participate in the call by dialing (855) 242-9918 and entering the passcode 9999284. A replay of the conference call will be available...

Continue reading

AgJunction Sets Third Quarter 2019 Conference Call for Thursday, November 7, 2019, at 11:00 a.m. ET

SCOTTSDALE, Ariz., Oct. 23, 2019 (GLOBE NEWSWIRE) — AgJunction Inc. (TSX: AJX), the Autosteering Company™, will hold a conference call on Thursday, November 7, 2019, at 11:00 a.m. Eastern time to discuss its financial results for the third quarter ended September 30, 2019. The company will report its financial results in a press release prior to the conference call.AgJunction management will host the conference call, followed by a question and answer period.Date: Thursday, November 7, 2019Time: 11:00 a.m. Eastern time (8:00 a.m. Pacific time)Toll-free dial-in number: 1-877-573-5992International dial-in number: 1-270-215-9903Conference ID: 4066529Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference...

Continue reading

Bellerophon Presents New Positive Data from Cohort 1 of Ongoing Phase 2/3 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease at CHEST 2019 Annual Meeting

Results Presented in Late-Breaking Abstract as an Oral PresentationPresentation Will Also be Published in the Highlights from CHEST Special EditionWARREN, N.J., Oct. 23, 2019 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, presented additional new data from Cohort 1 of its ongoing Phase 2/3 randomized, double-blind, placebo-controlled clinical study (iNO-PF) of INOpulse® for the treatment of Pulmonary Hypertension associated with Interstitial Lung Disease (PH-ILD) as a late-breaking oral presentation at the American College of Chest Physicians (CHEST) 2019 Annual Meeting in New Orleans.  The data were presented by Steven D. Nathan, M.D., F.C.C.P., Medical Director of the Advanced Lung Disease and Lung Transplant Program at Inova Fairfax...

Continue reading

PCSB Financial Corporation Announces First Fiscal Quarter Financial Results and Declares Quarterly Cash Dividend

YORKTOWN HEIGHTS, N.Y., Oct. 23, 2019 (GLOBE NEWSWIRE) — PCSB Financial Corporation (the “Company”) (NASDAQ: PCSB), parent of PCSB Bank (the “Bank”), today announced its results for the three months ended September 30, 2019. For the three months ended September 30, 2019, net income was $2.8 million, or $0.18 per share, compared to $1.7 million, or $0.10 per share, for the three months ended June 30, 2019 and $2.3 million, or $0.14 per share, for the three months ended September 30, 2018.On a non-GAAP basis, which excludes certain nonrecurring items, the Company recorded adjusted net income of $2.4 million, or $0.15 per diluted share for the three months ended September 30, 2019 as compared to adjusted net income of $1.6 million, or $0.10 per diluted share for the three months ended June 30, 2019 and $2.2 million, or...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.